Arom Yun

Arom Yun is an associate in Goodwin’s Antitrust and Competition practice. Prior to joining Goodwin, Arom was a senior associate in the antitrust practice at Shin & Kim LLP in South Korea.

Arom’s recent representative experience includes:

• Blueprint Medicines in its acquisition by Sanofi for $9.5 billion
• Vigil Neuroscience in its acquisition by Sanofi
• Dren Bio in Sanofi’s acquisition of Dren Bio’s bispecific myeloid cell engager
• FalconX in its acquisition of Arbelos Markets
• SafeSend it is acquisition by Thomson Reuters
• SciAps in its acquisition by Spectris
• Envato Pty Ltd in its $285 million acquisition by Shutterstock, Inc.
• Nasuni in its acquisition by Vista Equity Partners
• Paulus (d/b/a LetsGetChecked) in its acquisition of Truepill